Patents by Inventor Gluseppina Ortu

Gluseppina Ortu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy
    Patent number: 6562319
    Abstract: Radiolabeled epidermal growth factor receptor tyrosine kinase (EGFR-TK) irreversible inhibitors and their use as biomarkers for medicinal radioimaging such as Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) and as radiopharmaceuticals for radiotherapy are disclosed.
    Type: Grant
    Filed: March 12, 2001
    Date of Patent: May 13, 2003
    Assignees: Yissum Research Development Company of the Hebrew University of Jerusalem, Hadasit Medical Research Services and Development Ltd.
    Inventors: Eyal Mishani, Iris Ben-David, Yulia Rozen, Gluseppina Ortu, Alexander Levitzki
  • Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy
    Publication number: 20020128553
    Abstract: Radiolabeled epidermal growth factor receptor tyrosine kinase (EGFR-TK) irreversible inhibitors and their use as biomarkers for medicinal radioimaging such as Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) and as radiopharmaceuticals for radiotherapy are disclosed.
    Type: Application
    Filed: March 12, 2001
    Publication date: September 12, 2002
    Applicant: Hadasit Medical Research Services and Development Ltd.
    Inventors: Eyal Mishani, Iris Ben-David, Yulia Rozen, Gluseppina Ortu, Alexander Levitzki